Company Summary
Search
Home Page
 
SQI Diagnostics Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
September 30SuspendN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
11/Sep/2003  Canada   
Exchange Filing Office
Location
NEX Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Healthcare Information Technology  News Release March 3, 2015-SQI Diagnostics is a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Company's proprietary microarray tests and fully-automated systems are designed to simplify protein and antibody testing workflow, increase throughput, reduce costs and provide excellent data quality. 
Securities
SymbolSecurity NameMarketStatus
SQD.HSQI Diagnostics IncTSX VentureSUSPEND
Name HistoryFromTo
SQI Diagnostics Inc.4/May/2007Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  Mintz & Partners LLP
Investor Relations:  Renmark Financial Communications Inc.
Subsidiary:  SQI Diagnostics Systems Inc.
Transfer Agent:  Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  15/Jun/2021  NEWS RELEASE - SQI DIAGNOSTICS INC. ANNOUNCES $3.9 MILLION FUNDING VIA WARRANT EXERCISE BY INSIDERS[CANADA NEWSWIRE]
    NEWS RELEASE - SQI DIAGNOSTICS AND MCMASTER UNIVERSITY ANNOUNCE $900 000 COLLABORATIVE RESEARCH AND DEVELOPMENT GRANT[CANADA NEWSWIRE]
    NEWS RELEASE - SQI DIAGNOSTICS SUBMITS RALI-DX(TM) IL-6 SEVERITY TRIAGE TEST FOR COVID-19 PATIENTS TO FDA FOR EMERGENCY USE AUTHORIZATION[CANADA NEWSWIRE]
Bulletins  15/Feb/2024  Remain Suspended
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data